###begin article-title 0
Brain IGF-1 Receptors Control Mammalian Growth and Lifespan through a Neuroendocrine Mechanism
###end article-title 0
###begin article-title 1
Brain Growth Receptors Control Lifespan
###end article-title 1
###begin p 2
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 447 452 <span type="species:ncbi:10090">mouse</span>
Mutations that decrease insulin-like growth factor (IGF) and growth hormone signaling limit body size and prolong lifespan in mice. In vertebrates, these somatotropic hormones are controlled by the neuroendocrine brain. Hormone-like regulations discovered in nematodes and flies suggest that IGF signals in the nervous system can determine lifespan, but it is unknown whether this applies to higher organisms. Using conditional mutagenesis in the mouse, we show that brain IGF receptors (IGF-1R) efficiently regulate somatotropic development. Partial inactivation of IGF-1R in the embryonic brain selectively inhibited GH and IGF-I pathways after birth. This caused growth retardation, smaller adult size, and metabolic alterations, and led to delayed mortality and longer mean lifespan. Thus, early changes in neuroendocrine development can durably modify the life trajectory in mammals. The underlying mechanism appears to be an adaptive plasticity of somatotropic functions allowing individuals to decelerate growth and preserve resources, and thereby improve fitness in challenging environments. Our results also suggest that tonic somatotropic signaling entails the risk of shortened lifespan.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin title 4

###end title 4
###begin p 5
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 33 39 <span type="species:ncbi:9606">humans</span>
###xml 781 786 <span type="species:ncbi:9606">human</span>
###xml 874 880 <span type="species:ncbi:9606">people</span>
Using a mouse model relevant for humans, we showed that lifespan can be significantly extended by reducing the signaling selectively of a protein called IGF-I in the central nervous system. This effect occurred through changes in specific neuroendocrine pathways. Dissecting the pathophysiological mechanism, we discovered that IGF receptors in the mammalian brain efficiently steered the development of the somatotropic axis, which in turn affected the individual growth trajectory and lifespan. Our work confirms experimentally that continuously low IGF-I and low growth hormone levels favor extended lifespan and postpone age-related mortality. Together with other recent reports, our results further challenge the view that administration of GH can prevent, or even counteract human aging. This knowledge is important since growth hormone is often prescribed to elderly people in an attempt to compensate the unwanted effects of aging. Growth hormone and IGF-I are also substances frequently used for doping in sports.
###end p 5
###begin p 6
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Inactivating IGF receptors in the brain decreased growth hormone and IGF-I, and increased lifespan in healthy mice. Such neuroendocrine longevity could be a physiological response to environment.
###end p 6
###begin title 7
Introduction
###end title 7
###begin p 8
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b001">1</xref>
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b002">2</xref>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b003">3</xref>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b005">5</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b006">6</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b007">7</xref>
###xml 315 322 315 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lit/lit</sup>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b008">8</xref>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b009">9</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b010">10</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b011">11</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b012">12</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b013">13</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b014">14</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b015">15</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b016">16</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b017">17</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b018">18</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b019">19</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b020">20</xref>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b022">22</xref>
###xml 1543 1545 1543 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b023">23</xref>
###xml 1769 1771 1769 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b024">24</xref>
###xml 1772 1774 1772 1774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b029">29</xref>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 592 598 <span type="species:ncbi:9606">humans</span>
###xml 1978 1983 <span type="species:ncbi:10090">mouse</span>
Growth hormone (GH) and insulin-like growth factors (IGFs) promote mammalian growth [1,2] and contribute to metabolic regulation [3-5]. In contrast, inhibiting the actions of GH or IGF extends lifespan: mice constitutively lacking growth hormone receptor (GHR knockout [6,7]) or GH-releasing hormone receptor (GHRHRlit/lit mutant [8,9]), or mice with fewer IGF receptors [10], no insulin-receptor substrate 1 (IRS1) [11], or diminished IRS2 [12] live longer. This powerful effect of insulin-like signals on longevity was discovered in nematodes [13,14] and insects [15,16], but may extend to humans: functionally relevant IGF receptor (IGF-1R) mutations have recently been discovered in centenarians [17], and conditions of low IGF-I, PI3K, IRS1, GH, and GHRH correlate with prolonged lifespan [18,19]. Significantly, the regulation of aging in diverse species involves common major hormonal pathways, and the underlying mechanisms have clearly been conserved through evolution. Several lines of evidence suggest that the fundamental biological process might be an adaptive mechanism enabling individuals to adjust body size, metabolism, and lifespan to their environment, in particular to the challenging natural fluctuations of resources [20-22]. Such an adaptive mechanism would require individual plasticity, especially of the somatotropic hormone axis in response to environmental cues. Because the development of this hormone axis is steered by the central nervous system (CNS) through hypothalamic control of pituitary differentiation [23], it is possible that any somatotropic plasticity would involve the CNS. Indeed, previous work in nematodes and insects showed that insulin-like signals in the nervous system alter survival in a non-cell autonomous manner [24-29], suggesting that neuronal control of aging through insulin-like signals might also be conserved. To test these ideas experimentally in a mammalian model, we genetically manipulated IGF signaling in the mouse brain and explored growth, metabolism, and lifespan in these mutants.
###end p 8
###begin p 9
###xml 99 103 <span type="species:ncbi:10090">mice</span>
We found that brain IGF receptors strongly promote the development of the somatotropic function in mice. We show that developmental IGF signaling in the brain selectively determines somatotropic plasticity, regulates GH and IGF-I secretion, and thereby controls growth of peripheral tissues, adult glucose metabolism, and energy storage, as well as survival and mortality.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Brain IGF-1R Regulates Growth Hormone
###end title 11
###begin p 12
###xml 149 156 149 156 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 156 159 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 165 172 165 172 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 205 213 205 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g001">Figure 1</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g001">1</xref>
###xml 404 411 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 416 423 416 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-se001">Text S1</xref>
###xml 483 490 483 490 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 490 493 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 665 674 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg001">Figure S1</xref>
###xml 732 735 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 861 870 861 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg001">Figure S1</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg001">S1</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b020">20</xref>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b021">21</xref>
###xml 1079 1081 1079 1081 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (</sc>
###xml 1082 1089 1082 1089 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 1089 1092 1089 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1165 1173 1165 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g001">Figure 1</xref>
###xml 1217 1226 1217 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg002">Figure S2</xref>
###xml 1335 1343 1335 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g002">Figure 2</xref>
###xml 1361 1368 1361 1368 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 1368 1371 1368 1371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1433 1434 1431 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1470 1471 1466 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1478 1479 1474 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1515 1516 1509 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1552 1553 1544 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1560 1561 1552 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1606 1607 1598 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1618 1626 1610 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-st001">Table S1</xref>
###xml 1630 1637 1622 1629 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 1637 1640 1629 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1698 1706 1690 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g001">Figure 1</xref>
###xml 1795 1802 1787 1794 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 1802 1805 1794 1797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1859 1867 1851 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g002">Figure 2</xref>
###xml 1929 1937 1921 1929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g002">Figure 2</xref>
###xml 2078 2086 2070 2078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g002">Figure 2</xref>
###xml 2207 2214 2199 2206 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 2214 2217 2206 2209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2266 2274 2258 2266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g002">Figure 2</xref>
###xml 2461 2469 2453 2461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g002">Figure 2</xref>
###xml 2577 2585 2569 2577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g003">Figure 3</xref>
###xml 2924 2931 2916 2923 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 2931 2934 2923 2926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 3052 3060 3044 3052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g003">Figure 3</xref>
###xml 3066 3067 3058 3059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g003">3</xref>
###xml 3246 3254 3238 3246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g003">Figure 3</xref>
###xml 3260 3261 3252 3253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g003">3</xref>
###xml 3417 3425 3409 3417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g003">Figure 3</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 1641 1645 <span type="species:ncbi:10090">mice</span>
###xml 2218 2222 <span type="species:ncbi:10090">mice</span>
###xml 2935 2939 <span type="species:ncbi:10090">mice</span>
To study the role of IGF signaling in the CNS, we generated mice with heterozygous and homozygous brain-specific IGF-1 receptor knockout mutations (bIGF1RKO+/- and bIGF1RKO-/-) by conditional mutagenesis (Figure 1A and 1B). Mutants and their controls were littermates with identical genetic background, and matings were performed such that the Nestin-Cre transgene was always paternally transmitted (see Methods and Text S1 for breeding and genetic background). Homozygous mutants (bIGF1RKO-/-) have no IGF-1R on CNS neurons or glia. They were microcephalic and developed a complex phenotype involving severe growth retardation, infertility, and abnormal behavior (Figure S1). Though very interesting per se, the homozygous bIGF1RKO-/- mice did not show extended lifespan and their adult plasma IGF-I concentration was significantly higher than control values (Figure S1E and S1G). Thus, homozygous mutants were not a suitable model for healthy longevity, which is generally associated with diminished insulin-like signaling [20,21]. We therefore studied the heterozygous mutants (bIGF1RKO+/-), in which the IGF-1R levels in the CNS are half that in the wild-type (Figure 1C). They were healthy and behaved normally (Figure S2). Their body growth, however, though initially normal, was progressively retarded from 20 d of age onwards (Figure 2A). By age 90 d, bIGF1RKO+/- adults weighed about 90% of controls (males, 30.5 +/- 0.6 g, n = 12 versus 33.7 +/- 0.4 g, -9.6%, n = 19, p < 0.0001; females, 24.1 +/- 0.3 g, n = 18 versus 26.2 +/- 0.5 g, -7.9%, n = 14, p < 0.001) and were 5% shorter than controls (p < 0.001) (Table S1). bIGF1RKO+/- mice had normal IGF-1R levels in peripheral tissues (see Figure 1C), so we speculated that endocrine growth regulation during development was disturbed. bIGF1RKO+/- pituitaries were indeed small from age 10 d onwards (Figure 2B), and total GH content remained low throughout development (Figure 2C). The GH concentration per milligram protein fell at age 20 d, suggesting that retardation of early postnatal somatotroph differentiation (Figure 2D) started between day 10 and day 20. Plasma IGF-I, which strongly depends on GH, did not show any pubertal increase in bIGF1RKO+/- mice while controls displayed the normal surge (Figure 2E). Moreover, the concentration of the acid labile subunit (ALS), an important regulator of IGF-I stability and itself regulated by GH, was very low in mutants throughout postnatal life (Figure 2F). Importantly, in this model the IGF-1R gene is knocked out in the hypothalamus but not in the pituitary (Figure 3A). Therefore, we suspected that this somatotropic phenotype was caused by alterations in GH-regulatory neurons of the hypothalamus, i.e. arcuate nucleus GHRH neurons and anterior periventricular somatostatin (SRIH) neurons whose endings converge on the external layer of the median eminence (ME). Indeed, hypothalamic GHRH expression in bIGF1RKO+/- mice was significantly low, and GHRH accumulation in the GHRH neuron endings was clearly diminished around age 10 d (Figure 3B and 3C). In contrast, hypophysiotropic SRIH-producing neurons in the hypothalamus exhibited a normal abundance of SRIH at age 10 d, evidence of the cell-specificity of this phenotype (Figure 3B and 3D). Accordingly, Pit-1 expression, which is controlled by GHRH neurons and steers somatotropic cell differentiation, was half normal in mutant pituitaries (Figure 3E).
###end p 12
###begin title 13
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r</italic>
Brain-Targeted Inactivation of the Igf1r Gene Using Cre-lox Mutagenesis
###end title 13
###begin p 14
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre</italic>
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rosa26R</italic>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b033">33</xref>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre</italic>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
(A) CNS-specific Cre-lox recombination demonstrated using X-Gal staining (blue) in a sagittal section from a 2-wk-old NesCre+/0 mouse harboring a LacZ reporter (Rosa26R+/0) [33]. NesCre is expressed in neuroepithelium by neuronal and glial precursors. Abbreviations: Br, brain; FT, fat tissue; He, heart; Int, intestine (with bacterial artifacts); Li, liver; OE, olfactory epithelium (red arrow).
###end p 14
###begin p 15
###xml 37 44 37 44 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 126 130 126 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 121 130 121 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r<sup>flox</sup></italic>
(B) Southern blot analysis of adult bIGF1RKO+/- tissues revealed complete recombination in the brain (Br) and the intact Igf1rflox allele in all peripheral tissues (left panel). Recombination in peripheral tissues was minimal. The IGF-1R knockout was effective throughout the brain (right panel) and stable through time (unpublished data). The restriction enzymes used were HincII and I-SceI (left blot) and HincII alone (right). Cb, cerebellum, Cx, cortex, Ki, kidney, Lu, lung, M, DNA size marker, M1/M2, skeletal muscle, Ob, olfactory bulb, Po, pons, Sk, skin, Sp, spleen, St, striatum, Th, thalamus, Ts, testis.
###end p 15
###begin p 16
###xml 5 12 5 12 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
(C) bIGF1RKO+/- mice had normal IGF-1R levels in peripheral tissues (e.g., muscle) and approximately50% of normal levels in the CNS (here: hypothalamus and cortex), as assessed by western blotting.
###end p 16
###begin title 17
###xml 80 84 <span type="species:ncbi:10090">Mice</span>
Growth and Postnatal Development of the Somatotropic Axis in Mutant and Control Mice
###end title 17
###begin p 18
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
(A) bIGF1RKO+/- mice had significantly delayed growth, from age 18 d onwards.
###end p 18
###begin p 19
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(B) bIGF1RKO+/- pituitaries were small from age 10 d onwards (n = 10 per group).
###end p 19
###begin p 20
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(C) Pituitaries from mutants contained little GH (n = 5 per group).
###end p 20
###begin p 21
(D) Data from (C) expressed per milligram of pituitary protein revealing a selective drop at age 20 d.
###end p 21
###begin p 22
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
(E) In control mice, serum IGF-I increased rapidly after age 10 d (in response to endogenous GH), but remained low in bIGF1RKO+/- mice.
###end p 22
###begin p 23
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
(F) Similar to IGF-I (E), the postnatal surge of ALS in controls was absent from bIGF1RKO+/- mice (n = 5 per group).
###end p 23
###begin title 24
Somatotropic Signals in the Hypothalamic-Pituitary Complex
###end title 24
###begin p 25
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre</italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 121 129 121 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Rosa26R</italic>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre</italic>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r</italic>
###xml 597 601 597 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r</italic>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
(A) Efficient Cre-lox recombination in hypothalamus, not in pituitary, as shown by X-Gal-staining of a sagittal NesCre+/0;Rosa26R+/0 brain section: the anterior pituitary originates from the pharyngeal wall, not from neuroepithelium, to which NesCre transgene expression is confined. Abbreviations: 3V, third ventricle; aP, anterior pituitary; Bo, bone; Hpt, hypothalamus; Inf, infundibulum; iP, intermediate pituitary; ME, median eminence; pP, posterior pituitary; R, recessus of the third ventricle. PCR analysis of genomic DNA confirmed absence of recombination from the pituitary: intact Igf1rflox alleles in pituitary, and knockout (Igf1r-) alleles prevalent in hypothalamus.
###end p 25
###begin p 26
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 153 154 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 163 164 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 239 240 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 326 329 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 558 561 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 623 624 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 630 631 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
(B) GHRH immunoreactivity (red) at nerve endings in the ME was weaker than control in bIGF1RKO+/- mice (65 +/- 6 versus 122 +/- 10 au (arbitrary units), p < 0.01, n = 3), whereas SRIH (green) was unaffected (191 +/- 3 versus 197 +/- 5 au, n = 3). Briefly, ME tissue sections from the same anatomical location in three bIGF1RKO+/- and three control 10-day-old males were subjected to IHC. Micrographs were taken under identical conditions. For each animal, data from ten sections were averaged. The ratio of GHRH to SRIH immunoreactivity was lower in bIGF1RKO+/- than in control animals (0.34 +/- 0.05 versus 0.54 +/- 0.09, n = 6; p = 0.06).
###end p 26
###begin p 27
(C) Similarly, GHRH gene expression (measured by quantitative real-time RT-PCR, relative to beta-actin) was lower at age 10 d in mutants than controls.
###end p 27
###begin p 28
(D) SRIH expression was similar in mutants and controls.
###end p 28
###begin p 29
###xml 58 65 58 65 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(E) Pit-1 expression (relative to 18S rRNA) was lower in bIGF1RKO+/- than wild-type pituitaries at age 10 d.
###end p 29
###begin p 30
###xml 56 63 56 63 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 170 178 170 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g004">Figure 4</xref>
###xml 225 232 225 232 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 299 307 299 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-st001">Table S1</xref>
###xml 396 404 396 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g004">Figure 4</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g004">4</xref>
###xml 554 562 554 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g004">Figure 4</xref>
###xml 667 675 667 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g004">Figure 4</xref>
###xml 791 798 791 798 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 798 801 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 871 872 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 934 935 926 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 947 955 939 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g004">Figure 4</xref>
###xml 1195 1204 1187 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg003">Figure S3</xref>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
This early somatotropic deficiency persisted: in adult bIGF1RKO+/- hypothalamus, the GHRH concentration remained low, while the abundance of antagonistic SRIH increased (Figure 4A). Consistent with these observations, adult bIGF1RKO+/- pituitaries were small (males, -40%; females, -33%; p < 0.001; Table S1), contained many fewer GH-producing cells, and were GH depleted compared with controls (Figure 4A right, 4B). Peripheral tissues showed diverse evidence of chronic lack of GH stimulation: Liver GH receptors were hypersensitive to GH stimulation (Figure 4C), and several markers of peripheral GH action were abnormally low in adults (IGFBP-3, -37%; ALS, -53%; Figure 4D; serine protease inhibitor Spi2.1, -53%, unpublished data). As expected, plasma IGF-I levels were lower in adult bIGF1RKO+/- mice than controls (males, 243 +/- 10 versus 453 +/- 15 ng/ml, -46%, p < 0.0001; females, 321 +/- 13 versus 442 +/- 16 ng/ml, -27%, p < 0.0001) (Figure 4D, right). Finally, IGF-1R was consistently underphosphorylated in major peripheral tissues (e.g. skeletal muscle: between 51% and 67% of control levels, depending on age, as determined by IGF-1R immunoprecipitation and western immunoblot; Figure S3), clearly indicating that cells were receiving less than wild-type IGF-I stimulation.
###end p 30
###begin title 31
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
GH/IGF-I Deficiency in Adult bIGF1RKO+/-
###end title 31
###begin p 32
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 286 289 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 341 342 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
(A) Hypothalamic GHRH was higher (left) and SRIH lower (middle) in bIGF1RKO+/- than control mice at age 9 mo. Pituitary GH was markedly low (right). The wet weight of the hypothalamus and total proteins extracted from hypothalamus in mutants did not differ from control values (bIGF1RKO+/- 1.55 +/- 0.12 mg versus controls 1.53 +/- 0.10 mg, p = 0.86, NS).
###end p 32
###begin p 33
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(B) GH immunoreactivity (red) was much lower in bIGF1RKO+/- than control pituitaries, here in frontal sections through the lateral half gland with DAPI (blue) nuclear counter-stain. aP, anterior pituitary; iP, intermediate pituitary; pP, posterior pituitary.
###end p 33
###begin p 34
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(C) Liver GH receptor (upper) and Jak2 (lower panel) were overphosphorylated upon administration of GH into the portal vein, indicating hypersensitivity of GHR (n = 4 per group; paired t-test). Right: representative western blots.
###end p 34
###begin p 35
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
(D) IGF-binding protein-3 (IGFBP-3, left), ALS (middle), and circulating IGF-I (right) were significantly less abundant in bIGF1RKO+/- mice than controls, indicative of deficient peripheral GH action. IGFBP-3 and ALS (and also Spi2.1, see text) were determined only in males.
###end p 35
###begin title 36
Gonado- and Thyrotropic Functions Are Preserved
###end title 36
###begin p 37
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 299 300 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 495 498 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 597 598 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 690 691 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 834 835 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 892 895 866 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 946 947 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1142 1145 1112 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1160 1161 1128 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1203 1204 1168 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1273 1276 1238 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1291 1292 1254 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1334 1335 1294 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1342 1343 1302 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1422 1425 1382 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1487 1488 1431 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1516 1519 1460 1463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1581 1582 1509 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1666 1675 1594 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg002">Figure S2</xref>
###xml 1681 1683 1609 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg002">S2</xref>
To determine whether the observed hypothalamic inhibition of endocrine GH and IGF-I was specific, we assessed gonado- and thyrotropic functions in mutant animals by monitoring fertility, reproduction, and energy metabolism. bIGF1RKO+/- females were fertile and had normal litters (7.1 +/- 0.7 pups, n = 6 litters). Ovarian cycling, controlled by anterior pituitary follicle-stimulating hormone (FSH), luteinizing hormone (LH), and their hypothalamic releasing hormones, was identical in bIGF1RKO+/- and control females (mean estrous cycle length, at 4 mo of age, 5.1 +/- 0.3 versus 4.9 +/- 0.3 d, n = 15, not significant [NS]; at approximately9 mo of age, 5.3 +/- 0.2 versus 5.9 +/- 0.4 d, n = 37, NS). Moreover, there was no difference in pro-estrus estradiol concentration in adult females (82.3 +/- 6.3 versus 85.2 +/- 5.0 pmol/l, n = 39, NS) nor in ovary size relative to weight (bIGF1RKO+/- 0.36 +/- 0.01 versus controls 0.38 +/- 0.02 mg/g, n = 72, NS); therefore we considered gonadotropic function to be normal. Plasma thyroxin (T4) levels, controlled by pituitary thyroid-stimulating hormone (TSH) were unaffected in females (bIGF1RKO+/- 29.1 +/- 1.4, n = 19 versus controls 27.5 +/- 1.6 mug/l, n = 12, NS) and, although they were moderately high in males (bIGF1RKO+/- 39.0 +/- 2.0, n = 14 versus controls 30.0 +/- 1.0 mug/l, n = 20, p < 0.005), we observed no differences in core body temperature (males, bIGF1RKO+/- 36.7 +/- 0.3 degreesC versus controls 37.0 +/- 0.4 degreesC, n = 15, NS; females, bIGF1RKO+/- 37.4 +/- 0.1 degreesC versus controls 37.5 +/- 0.1 degreesC, n = 21, NS), nor did we find abnormalities in physical activity or food consumption (Figure S2A and S2B). Hence, we concluded that thyrotropic function also was in the normal range. In addition, the development of gonado- and thyrotropic phenotypes between 4 and 9 mo of age did not suggest that these functions differed thereafter.
###end p 37
###begin title 38
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 41 45 <span type="species:ncbi:10090">Mice</span>
Energy Storage Is Altered in bIGF1RKO+/- Mice
###end title 38
###begin p 39
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 309 316 309 316 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 316 319 316 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-st001">Table S1</xref>
###xml 456 464 456 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g005">Figure 5</xref>
###xml 467 475 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-st002">Table S2</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b030">30</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b032">32</xref>
###xml 752 755 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 873 874 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 885 893 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g005">Figure 5</xref>
###xml 940 943 932 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 967 975 959 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-st003">Table S3</xref>
###xml 1264 1265 1252 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1282 1283 1270 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1347 1348 1331 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1365 1366 1349 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 665 670 <span type="species:ncbi:10090">mouse</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
Weight gain with age was slightly greater for adult bIGF1RKO+/- mice than for controls (unpublished data), such that female mutants finally attained the same weight as controls. We analyzed body composition in 10-mo-old animals, and as suggested by growth curves and circulating IGF-I levels, most organs in bIGF1RKO+/- mice were smaller than those in controls (Table S1). Adipose tissue (AT), in contrast, was significantly enlarged in males and females (Figure 5A; Table S2). In both sexes, the largest increase was in subcutaneous AT, whereas visceral AT was less increased in mutant females, and even slightly diminished in males, similar to other GH-deficient mouse models [30-32]. Accordingly, circulating leptin levels were excessive in bIGF1RKO+/- mice (males, 27.1 +/- 3.6 ng/ml versus 7.4 +/- 1.2 ng/ml; females, 15.5 +/- 1.0 ng/ml versus 6.5 +/- 0.5 ng/ml; both p < 0.0001; Figure 5B). At age 4 mo, blood biochemistry in bIGF1RKO+/- mice was still normal (Table S3), but at 10 mo, HDL and total cholesterol concentrations were high (unpublished data) and triglyceride (TG) and free fatty acid (FFA) concentrations in males significantly higher than in controls, probably due to the abundance of AT (TG, 1.36 +/- 0.12 mmol/l versus 1.03 +/- 0.09 mmol/l, n = 10 per group, p < 0.05; FFA, 0.65 +/- 0.04 mmol/l versus 0.48 +/- 0.03 mmol/l, n = 10 per group, p < 0.005). As circulating GH counteracts fat storage, these metabolic traits may be secondary to the observed somatotropic defect.
###end p 39
###begin title 40
Exploration of Adult Energy Metabolism
###end title 40
###begin p 41
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(A) bIGF1RKO+/- adipocytes from inguinal AT were abnormally enlarged.
###end p 41
###begin p 42
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
(B) Leptinemia was very high in bIGF1RKO+/- mice, and strongly correlated with individual total AT size in all animals (R = 0.76, p < 0.0001, n = 82).
###end p 42
###begin p 43
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(C) Glucose tolerance was impaired in bIGF1RKO+/- males and females.
###end p 43
###begin p 44
###xml 53 55 53 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</italic>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(D) 30 min after intraperitoneal glucose injection (T30), the plasma insulin concentration was, as expected, significantly increased in mutants and controls. However, although bIGF1RKO+/- females responded to elevated blood glucose with adequate hyperinsulinemia, bIGF1RKO+/- males did not, suggesting a secretory defect.
###end p 44
###begin p 45
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b003">3</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b010">10</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b033">33</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b034">34</xref>
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 304 312 304 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g005">Figure 5</xref>
###xml 422 425 422 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 477 480 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 488 496 488 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g005">Figure 5</xref>
###xml 655 658 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
Mice with peripheral resistance to IGF-I or with low GH and IGF-I activity generally display altered glucose metabolism [3,10,33,34]. We therefore assessed glucose tolerance and insulin secretion in adult bIGF1RKO+/- mice and found moderate, but significant hyperglycemic responses in males and females (Figure 5C). Moreover, although insulin secretory response 30 min after glucose injection appeared adequate in bIGF1RKO+/- females, it was relatively insufficient in bIGF1RKO+/- males (Figure 5D). The impaired control of glucose homeostasis and enlarged fat tissue in adult mutants indicate that the lack of IGF-I and GH progressively affected bIGF1RKO+/- metabolism.
###end p 45
###begin title 46
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 12 16 <span type="species:ncbi:10090">Mice</span>
bIGF1RKO+/- Mice Live Longer Than Controls
###end title 46
###begin p 47
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b006">6</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b009">9</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b035">35</xref>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 339 340 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 367 368 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 375 376 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 386 394 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g006">Figure 6</xref>
###xml 492 500 488 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g006">Figure 6</xref>
###xml 506 507 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g006">6</xref>
###xml 581 588 577 584 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 588 591 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 657 664 653 660 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 664 667 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 697 698 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 748 755 744 751 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 755 758 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 820 827 816 823 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 827 830 823 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 959 966 955 962 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 966 969 962 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 994 1003 990 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg004">Figure S4</xref>
###xml 1048 1055 1044 1051 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 1055 1058 1051 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1223 1232 1219 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg005">Figure S5</xref>
###xml 1329 1336 1325 1332 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 1336 1339 1332 1335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
Constitutive inactivation of GHRH or GH receptors, as well as mutations impeding pituitary somatotroph development, increase longevity [6,9,35]. We therefore measured the lifespan of bIGF1RKO+/- and control mice. Survival curves showed that bIGF1RKO+/- mice had a significantly longer mean lifespan than control littermates (914 +/- 21 d, n = 27 versus 836 +/- 28 d, n = 42, p < 0.05) (Figure 6A). When we analyzed male and female mutants separately, we found similar increases in longevity (Figure 6B and 6C). However, the maximum life span was unchanged. The mortality rate for bIGF1RKO+/- mice up to 100 wk of age was six times lower than for controls (bIGF1RKO+/- 0.037 versus controls 0.238, p < 0.05). Thereafter, however, mortality rate of bIGF1RKO+/- increased sharply and was 55% higher for 121- to 140-wk-old bIGF1RKO+/- mice than controls in the same age range. Consequently, the inter-individual variation of lifespan was significantly lower for bIGF1RKO+/- mice than for controls (Figure S4). Thus, survival and mortality patterns in bIGF1RKO+/- mice under normal conditions were clearly affected. In contrast, we did not find differences in survival when mutants where challenged with acute oxidative stress (Figure S5), indicating that causes other than stress resistance were important for increased lifespan of bIGF1RKO+/- mice.
###end p 47
###begin title 48
Lifespan Analysis
###end title 48
###begin p 49
###xml 31 38 31 38 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF1RKO</sc>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
(A) Survival curves show that bIGF1RKO+/- mice, on average, outlived their control littermates, although the maximum lifespan was similar for mutants and controls.
###end p 49
###begin p 50
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 176 179 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(B and C) Separate survival curves for males and females. Mean lifespan for bIGF1RKO+/- males was 966 +/- 28 d versus 853 +/- 43 d for male controls; Mean lifespan for bIGF1RKO+/- females was 888 +/- 27 d versus 821 +/- 36 d for female controls. Differences were significant in Cox's test for males, females, and for both sexes combined when curves were censored before week 140, 130, and 135, respectively.
###end p 50
###begin p 51
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 374 377 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 518 521 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1058 1061 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1265 1268 1265 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1352 1353 1352 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
Post-mortem histopathology revealed a similarly diverse, heterogeneous panel of diseases in bIGF1RKO+/- and control mice. To allow statistical evaluation despite relatively few observations, we categorized pathologies as inflammatory, degenerative, or tumor-related. The prevalence of inflammatory diseases was similar (bIGF1RKO+/- 28% versus control mice 30%), but bIGF1RKO+/- mice tended to develop fewer degenerative diseases (22% versus 27%, NS) and fewer tumors (44% versus 53%, NS). Notably, none of the bIGF1RKO+/- animals over 130 wk of age showed pituitary tumors or hyperplasia, whereas 20% of the controls did, most probably a consequence of lifelong GHRH stimulation. However, as control animals had a fully normal lifespan, pituitary pathology was apparently not precipitating death. It was more likely that the reduced somatotropic tone in mutant mice protected them from death at an age by which a significant proportion of controls had already died. Concerning the prevalence of pathologies among those controls that die earlier than bIGF1RKO+/-, our data were nonconclusive, essentially due to the limited number of observations. Similarly, we could not find published information on early pathogenesis in B6/129 F1 hybrids. Finally, fewer bIGF1RKO+/- individuals than controls presented multiple pathologies at death (17% versus 47%, p = 0.2), consistent with a lower disease burden in mutants.
###end p 51
###begin title 52
Discussion
###end title 52
###begin title 53
IGF and Somatotropic Plasticity
###end title 53
###begin p 54
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b012">12</xref>
We showed that diminishing IGF-1R expression in the brain selectively reduced somatotropic function. This result suggests that brain IGF-1R controls the set-up of the GH/IGF axis, thereby modulating growth, energy metabolism, and lifespan. In contrast, complete absence of brain IGF-1R in the homozygous knockout produced a very different phenotype leading to increased IGF-I; thus, the phenotype is strongly dependent on IGF-1R gene dose. Any life-prolonging effects of early growth retardation in the homozygous mutant were subsequently suppressed, possibly by increased IGF-I. However, phenotypic alterations in the homozygote were so complex that comparing them with the heterozygote seemed a futile endeavor. Interestingly, brain-specific inactivation of IRS2, a major signal transduction molecule downstream from IGF-1R and insulin receptors, increased lifespan and altered nutrient homeostasis [12], while apparently not involving the somatotropic axis.
###end p 54
###begin p 55
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b036">36</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b009">9</xref>
###xml 737 740 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1603 1606 1603 1606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
The heterozygous bIGF1RKO+/- phenotype was somatotroph-specific and other neuroendocrine pathways were unaffected, implicating hypothalamic GHRH neurons. IGF receptors are indeed present in the arcuate nucleus where GHRH neurons reside. There is, however, little evidence for a specific developmental role for IGF-I in the regulation of GHRH neurons, and we cannot exclude the possibility that IGF-1R deletion from other brain areas affected GHRH neurons at a distance. Nevertheless, the similitude of bIGF1RKO+/- mice with mutants lacking GHRH neurons [36] or GHRH receptors [9] also indicated that this phenotype could have been caused by reduced GHRH signals to the pituitary. Importantly, the number of GH-producing cells in bIGF1RKO+/- pituitaries was only a fraction of that in controls. This finding was corroborated by immunohistochemistry (IHC) and concordant with the several-fold reduced pituitary GH content. GH depletion, in turn, explains the very low ALS concentration and absence of the pubertal surge in IGF-I. As the reduction in GHRH was proportionate to hypothalamic IGF-1R dose, GHRH action presumably triggers a disproportionate loss of GH cells. Several mechanisms may contribute to this: GHRH regulates the number of GH-positive cells, as well as GH production and secretion. Most likely, GHRH abundance must be above a certain threshold to stimulate hypothalamic-pituitary development and GH production. Moreover, not only GHRH but also SRIH neurons, which determine adult GH secretion, may be sensitive to IGF. SRIH was indeed above control concentrations in the adult bIGF1RKO+/- hypothalamus, suggesting that coordinate GHRH and SRIH action on somatotrophs may have contributed to the observed over-proportionate effects.
###end p 55
###begin p 56
###xml 214 217 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 677 680 677 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 811 812 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 822 823 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 860 869 856 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg003">Figure S3</xref>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
GHRH and SRIH accumulate in nerve endings at the ME, and are liberated into portal veins to regulate pituitary GH. During development, somatotroph proliferation and differentiation depend on local GHRH. In bIGF1RKO+/- hypothalamus, immunoreactive GHRH but not SRIH was less abundant than in controls. This difference in amount suggests a shift from GHRH to SRIH stimulation at the ME and has possible functional implications for pituitary development, e.g. via Pit-1. Early lack of GHRH in ME, as observed here, may be due to less GHRH neurons, fewer nerve endings, or diminished GHRH. Although we cannot conclude from our experiments, IGF receptors in the ME of adult bIGF1RKO+/- appeared to be less phosphorylated than those in the rest of the hypothalamus (38.8 +/- 2.6 versus 59.0 +/- 4.9, arbitrary units, p = 0.005, n = 8; no difference in control mice; Figure S3B). Thus, ME may participate in somatotropic control, for instance by sensing circulating IGF-I. The ME also harbors numerous tanycytes, glia specialized in IGF-I transport to the brain, that may contribute to the modulation of somatotropic signals by acting on the maturation of GHRH neurons. Our various findings combine to indicate that IGF-I, the principal peripheral mediator of GH action, itself plays a major role in the development of the GH/IGF axis.
###end p 56
###begin p 57
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b037">37</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b038">38</xref>
###xml 835 842 835 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-se001">Text S1</xref>
###xml 870 879 870 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg006">Figure S6</xref>
###xml 1126 1135 1126 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg007">Figure S7</xref>
###xml 1264 1266 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b039">39</xref>
###xml 1429 1430 1426 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b003">3</xref>
###xml 1431 1432 1428 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b004">4</xref>
Cells in small organisms communicate trophic status via paracrine insulin-like signals [37]. Our results suggest that IGF-I may have conserved a role of this type in complex organisms and act, in particular, during development as a trophic signal that represents numerous, distant tissues [38]. The neuroendocrine network of GHRH, SRIH, and GH cells evolved in vertebrates as a central regulator that coordinates growth of heterogeneous cell populations. Here, we describe a mechanism that determines the individual postnatal trajectory of the somatotropic axis and its adult set point. Somatotropic plasticity, as we observed here, may have evolved to adjust growth to environmental resources. We further demonstrated that early dietary restriction can trigger a neuroendocrine response similar to brain-specific IGF-1R knockout (see Text S1, Supplementary Results and Figure S6). Both genetic and nutritional intervention led to growth deficits and a lifelong reduction in endocrine IGF-I. Thus, it appears that a fairly direct hormonal path connects nutrition, somatotropic hormones and growth through a positive feedback (Figure S7). This view is supported by recent evidence that AT, a major indicator of postnatal nutrition, is an important source of IGF-I [39]. Also, the phylogenetically related insulin receptor (IR) on pancreatic beta-cells controls development of the insulin/IR hormone axis in a very similar manner [3,4].
###end p 57
###begin p 58
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 301 302 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 309 310 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 319 328 317 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg003">Figure S3</xref>
###xml 494 497 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 507 516 505 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg001">Figure S1</xref>
Heterozygous inactivation of brain IGF-1R led to a consistent somatotropic deficit, but without any detectable effects on other brain functions. Interestingly, we found that in the bIGF1RKO+/- brain, the remaining IGF receptors were overphosphorylated in the cerebral cortex (120% +/- 5% of controls, n = 16, p < 0.05; Figure S3A) but not in hypothalamus. This cortical IGF-1R activation may be due to a compensatory local increase of ligand. In contrast, complete absence of IGF-1R in bIGF1RKO-/- mutants (Figure S1) resulted in microcephaly, indicative of a neurotrophic role for IGF-1R. We conclude that the IGF-1R gene is heterosufficient with respect to neurotrophic action, but heteroinsufficient with regard to its role in regulating somatotropic plasticity.
###end p 58
###begin p 59
We showed that downregulation of somatotropic hormones postponed mortality and increased mean lifespan. The underlying developmental mechanism suggested that neuroendocrine control of lifespan may be physiologically relevant in mammals. Indeed, somatotropic plasticity may confer an evolutionary advantage: adaptation of individual body size to available resources would improve fitness in the face of environmental changes; control of size, energy metabolism, and lifespan contribute to preserving vital resources and to maintaining genetic diversity during periods of shortage. Therefore, the evolutionary significance of somatotropic plasticity may be that it cushions otherwise deleterious effects of selective pressure.
###end p 59
###begin p 60
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b040">40</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b041">41</xref>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 516 519 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 727 749 727 749 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b027">27</xref>
###xml 890 900 890 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b042">42</xref>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b043">43</xref>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 727 749 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 925 930 <span type="species:ncbi:9606">human</span>
The Barker hypothesis and predictive adaptive response (PAR) hypothesis claim that changes in development can have late consequences for health, modify mortality and lifespan, and entail a risk of maladaptation later in life, if environmental conditions differ grossly from those that led to the initial changes [40,41]. This may apply to bIGF1RKO+/- mice, adapted to a poor environment (little IGF signaling to the brain), when food was available ad libitum. The resulting dyslipidemia and hyperglycemia in bIGF1RKO+/- mutants may explain the rapid increase in late-life mortality and unusual combination of extended mean but normal maximum lifespan. Similar patterns of survival have been described in other aging models: in Caenorhabditis elegans, ablation of ASI sensory neurons that modulate DAF-2 pathways in response to environment, increased mean, but not maximum lifespan [27]; in Drosophila, targeted expression of human uncoupling protein 2 in adult neurons [42], or inhibition of p53 specifically in the nervous system [43], extended mean, but not maximum, lifespan. Common to these models is that the mutations were targeted to the nervous system, and it is possible that the perturbed neuronal responsiveness to environmental cues is the primary cause of prolonged lifespan in these models.
###end p 60
###begin p 61
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 279 288 279 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060254-g006">Figures 6</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060254-sg004">S4</xref>
###xml 1076 1079 1076 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1408 1410 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b044">44</xref>
###xml 1466 1468 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b045">45</xref>
###xml 1490 1492 1490 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b019">19</xref>
###xml 1794 1796 1794 1796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b017">17</xref>
###xml 1901 1903 1901 1903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b046">46</xref>
###xml 1985 1987 1985 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b047">47</xref>
###xml 2080 2081 2080 2081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1330 1334 <span type="species:ncbi:9615">dogs</span>
###xml 1586 1592 <span type="species:ncbi:9606">humans</span>
###xml 1612 1617 <span type="species:ncbi:9606">women</span>
###xml 1774 1779 <span type="species:ncbi:9606">human</span>
###xml 1833 1841 <span type="species:ncbi:9606">patients</span>
###xml 2027 2033 <span type="species:ncbi:9606">people</span>
###xml 2257 2262 <span type="species:ncbi:9606">human</span>
An alternative interpretation of our findings with bIGF1RKO+/- mice is possible. The average lifespan of the mutants was longer than controls, but its variability was half than that for controls. Thus, individuals on the short-lived edge of the normal lifespan distribution (see Figures 6 and S4) benefit most from reduced growth hormone and IGF-I: they respond with a lifespan extension of nearly 40%. This finding raises the question of why genetically homogeneous wild-type populations display large variability in lifespan. A current explanation is that initially small stochastic differences between individuals are subsequently amplified during development and adult life; however, the mechanism for this remains unclear. Our data indicate that a full complement of brain IGF-1R is required for generating a high somatotropic tone, and this eventually increases the risk of dying early. This mechanism may produce much of the lifespan heterogeneity observed in wild-type mice. Remarkably, the variability of plasma GH was several-fold higher in controls than in bIGF1RKO+/- mice, the mutants having continuously low GH levels (M. Holzenberger, L. Kappeler, and A. Bekaert, unpublished data). There are indeed other mammalian species where short lifespan can be related to elevated somatotropic signaling, and vice-versa. In dogs, small size and low IGF-I are determined by one particular IGF-I allele [44], and small breeds live twice as long as large breeds [45]. Van Heemst et al. [19] investigated the relationship between somatotropic function, adult height, and longevity in humans, and found that in women, genetically determined low GH and IGF-I signaling was beneficial for old age survival. Recently, functionally relevant IGF-1R mutations were isolated from human centenarians [17]. Persisting high GH in acromegalic patients after surgical treatment is predictive of premature death [46], and elevated IGF-I in elderly individuals correlates with increased mortality [47]. Furthermore, the average lifespan of people with pituitary gigantism (mean height 236 cm, n = 28) is only 44 y, roughly 20 y below the corresponding historical adult life expectancy. It would be extremely valuable to measure the consequences of somatotropic tone for human health and longevity in a variety of contexts to clarify these important issues.
###end p 61
###begin title 62
Methods
###end title 62
###begin title 63
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse genetics.
###end title 63
###begin p 64
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r<sup>flox</sup></italic>
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b048">48</xref>
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b049">49</xref>
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre</italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b050">50</xref>
###xml 316 322 316 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 311 322 311 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r<sup>flox/+</sup></italic>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 341 350 341 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre<sup>+/0</sup></italic>
###xml 375 381 375 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 370 391 370 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r<sup>flox/+</sup>;NesCre<sup>+/0</sup></italic>
###xml 454 463 454 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 449 463 449 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1r<sup>flox/flox</sup></italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
Igf1rflox mice [48,49] were maintained in a 129/Sv (129) genetic background and also backcrossed to C57BL/6 (B6) for >15 generations. The Nestin-Cre (NesCre) transgene (maintained in B6 for >15 generations) produces Cre recombinase in neural and glial precursors during early neural development [50]. By mating Igf1rflox/+ females (B6) with NesCre+/0 males we generated Igf1rflox/+;NesCre+/0 double mutants in a B6 background. These were mated with Igf1rflox/flox females (129) to produce experimental cohorts as fully reproducible F1 generations of B6/129 hybrid genetic background, composed of hetero- (+/-) and homozygous (-/-) brain-specific IGF-1R knockout mice (bIGF1RKO) and their littermate controls. F1 hybrids from pure inbred strains combine two advantages: reproducibility of genetic composition and so-called hybrid vigor, i.e. the absence of phenotypic defects that affect pure inbred strains. F1 hybrids are generally long-lived, like mice from mixed genetic backgrounds and some pure inbred strains, including C57BL/6. We conducted experiments according to institutional guidelines for the care of laboratory animals.
###end p 64
###begin title 65
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 65
###begin p 66
###xml 546 549 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 853 856 847 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 968 971 962 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1095 1098 1089 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1111 1114 1105 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 251 255 <span type="species:ncbi:10090">Mice</span>
###xml 420 425 <span type="species:ncbi:10090">mouse</span>
###xml 1066 1070 <span type="species:ncbi:10090">Mice</span>
Animals lived under SPF conditions in individually ventilated cages at 23 degreesC, with a 14/10-h light/dark cycle and free access to water and a commercial rodent diet (49% carbohydrate, 24% protein, 5% lipid, 12% humidity, 10% mineral, and fiber). Mice were separated from mothers on day 30 and housed six males or six females per cage, with both control and mutant genotypes in each cage. Cages were equipped with a mouse house to enhance social interaction and prevent male aggressiveness. We produced four cohorts. In cohort 1 (105 bIGF1RKO+/-, 116 control males) we analyzed somatotropic development. To minimize litter effects, they were trimmed to four to six pups per mother. For experiments, mutants and controls were always litter-matched and each group was composed of animals from at least three different litters. In cohort 2 (57 bIGF1RKO+/-, 51 controls) we studied growth, metabolism, behavior, hormones, and body composition. In cohort 3 (45 bIGF1RKO+/-, 60 controls) we analyzed additional blood variables, female fertility, and ovarian function. Mice of cohort 4 (27 bIGF1RKO+/-, 19 bIGF1RKO-/-, 42 controls) were checked daily, but otherwise left undisturbed until they died naturally. Single surviving females were housed with neighbors. Necropsy was performed on all animals. Brain, heart, lung, liver, kidney, and spleen were dissected post mortem and fixed in formalin for histology. We determined major pathologies present at death for 62 of the 88 animals.
###end p 66
###begin title 67
Postnatal growth.
###end title 67
###begin p 68
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were weighed daily until the age of 6 wk and weekly thereafter. For growth curves, we used sliding means of current weight and weight on the preceding and subsequent day (or week, for age >6 wk).
###end p 68
###begin title 69
Fertility and reproduction.
###end title 69
###begin p 70
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
Estrous cycle length was determined by daily monitoring of vaginal smear histology for 3 to 4 wk. Blood and ovaries were sampled between 11 a.m. and 14 p.m. on the pro-estrus day under pentobarbital anesthesia. Mean litter size was calculated from matings between bIGF1RKO+/- females and wild-type males.
###end p 70
###begin title 71
Body temperature.
###end title 71
###begin p 72
Rectal temperature was determined on three consecutive days. Measurement began within 10 s of immobilization, to avoid artifacts of stress-induced thermogenesis.
###end p 72
###begin title 73
Histology and immunohistochemistry.
###end title 73
###begin p 74
###xml 108 111 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 119 122 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 102 122 101 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre<sup>+/0</sup>;Rosa26R<sup>+/0</sup></italic>
###xml 129 131 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b033">33</xref>
###xml 141 144 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/0</sup>
###xml 134 144 133 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rosa26R<sup>+/0</sup></italic>
###xml 1379 1380 1370 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 670 676 <span type="species:ncbi:9986">rabbit</span>
###xml 698 704 <span type="species:ncbi:9986">rabbit</span>
###xml 719 723 <span type="species:ncbi:9925">goat</span>
###xml 795 799 <span type="species:ncbi:9925">goat</span>
###xml 805 811 <span type="species:ncbi:9986">rabbit</span>
###xml 826 832 <span type="species:ncbi:9793">donkey</span>
###xml 838 842 <span type="species:ncbi:9925">goat</span>
LacZ staining was performed on parasagittal 14-mum-thick cryosections from 2-wk-old double transgenic NesCre+/0;Rosa26R+/0 mice [33]. Rosa26R+/0 littermates served as negative controls. Sections were fixed in PAF, stained with X-Gal overnight and counterstained with orange G. Inguinal fat pads from males were quickly frozen and cryosections (50 mum; -30 degreesC) fixed in 4% paraformaldehyde (PAF) for hematoxylin staining. Digital micrographs in visible light were taken with an Olympus BX51 microscope. We detected GH in the pituitary, and GHRH and SRIH in the ME using standard fluorescent IHC. Sections 18 mum thick were fixed in PAF and incubated overnight with rabbit anti-GH (NIH-NIDDK), rabbit anti-GHRH, or goat anti-SRIH antibodies (Santa Cruz). Secondary antibodies were Alexa 546 goat anti-rabbit and Alexa 488 donkey anti-goat (Molecular Probes). For fluorescent IHC we used an Olympus BX612 microscope. To compare the relative intensities of IHC signals for GH, GHRH, and SRIH between mutants and controls, we processed all samples under identical conditions with respect to anatomical location, antibody incubation, laser intensity, and CCD image acquisition, in particular using identical parameters of signal integration. For each animal, data obtained from ten different tissue sections were averaged. Means were then compared between groups using Student's t-test.
###end p 74
###begin title 75
Western blotting.
###end title 75
###begin p 76
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b051">51</xref>
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
Immunoprecipitation and western blotting were as described previously [51]. Antibodies used were anti-IGF-1R beta-subunit (C20, Santa Cruz), anti-phospho-tyrosine (PY20, Transduction Laboratories), anti-mouse GHR (from G. Gudmundur and F. Talamantes), anti-ALS (AF1436, R&D Systems), anti-mouse P-Jak2 Tyr1007/1008 (Cell Signalling/Ozyme), anti-beta-tubulin (Oncogene Research), and anti-beta-actin (Sigma). We confirmed equal loading for each immunoblot. Bound antibody was revealed using peroxidase-conjugated secondary antibodies and ECL (Amersham Pharmacia Biotech). Signals were quantified using MacBas 2.5 (Fuji) or film autoradiography and NIH Image (for ALS).
###end p 76
###begin title 77
Biochemistry.
###end title 77
###begin p 78
###xml 851 853 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b052">52</xref>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
###xml 762 765 <span type="species:ncbi:10116">rat</span>
From blood samples we determined total bilirubin, HDL, and total cholesterol, triglycerides, creatinine, glucose, lactate, total protein, urea and total antioxidant status, using an Olympus Diagnostic Automat. We tested glucose tolerance in animals fasted for 14 h by intraperitoneal injection of 20%-D-glucose (2 g/kg body weight): glucose was assayed in tail blood at 0, 15, 30, 60, and 120 min using a hand-held photometer (Lifescan Glucotouch); insulinemia was measured at 0 and 30 min. We used RIA to determine plasma IGF-I (Diagnostic Systems Laboratories), insulin, leptin (both from Linco), and T4 (MP Biomedical). Estradiol concentrations were determined by RIA in 150 mul of mouse pro-estrus serum (Diasorin). Pituitary GH content was measured using a rat-specific RIA (Linco). GHRH and SRIH were quantified in sonicated hypothalami by RIA [52]. The BCAssay (Uptima UP40840A, Interchim) was used to determine pituitary and hypothalamic protein content.
###end p 78
###begin title 79
GH receptor stimulation.
###end title 79
###begin p 80
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Human recombinant GH (Serono) was injected into the portal vein of mice (0.5 mug/g body weight) under isoflurane anesthesia (Abbott Laboratories). Liver biopsies, taken at the time of injection and 2, 5, and 20 min later were immediately frozen for protein extraction.
###end p 80
###begin title 81
Real-Time Reverse Transcription-PCR.
###end title 81
###begin p 82
Total RNA from hypothalami and pituitaries were extracted with phenol-chloroform (RNAble; Eurobio) and aliquots of 1 mug were reverse transcribed (Transcriptor; Roche) using random hexamers (Promega) in the presence of RNAsine (Promega). Duplicates of 10 ng cDNA were used for real-time PCR amplification in an Applied Biosystem's PCR System 7300 and its reagents (GHRH, Mm00439100_m1; SRIH, Mm00436671_m1; NPY, Mm00445771_m1; Pit-1, Mm00476852_m1; GH, Mm00433590_g1; PRL, Mm005599949_m1; TSH-beta, Mm00437190_m1; LH-beta, Mm00656868_q1; beta-actin, 4352933E; 18S rRNA, 4333760F). We quantified mRNA using standard curves generated with a control sample and values were normalized to values for housekeeping gene mRNAs.
###end p 82
###begin title 83
Statistics.
###end title 83
###begin p 84
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 169 170 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 193 194 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 249 250 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 263 264 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 278 279 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 310 311 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For group comparison, we used two-tailed Student's t-test. Means are expressed +/- SEM. We determined the significance of survival curves by Cox's test, and used paired t, Mann-Whitney, and Chi2 tests where indicated. Levels of significance were *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, not significant (p >/= 0.05).
###end p 84
###begin title 85
Supporting Information
###end title 85
###begin title 86
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">Mice</span>
Phenotype of Mice with Homozygous IGF-1R Knockout in the CNS (bIGF1RKO-/-)
###end title 86
###begin p 87
###xml 111 112 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Homozygous knockout brains contained 11% of control IGF-1R levels (29 +/- 2 fmol/mg versus 278 +/- 22 fmol/mg, n = 14, determined by in vitro ligand-binding assay; unpublished data) stemming from cells of non-neuroepithelial origin, including blood vessels and meninges.
###end p 87
###begin p 88
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(A) Unlike heterozygous bIGF1RKO+/-, the homozygotes were growth retarded at birth (approximately80% of normal birth weight), and their cranium was flat.
###end p 88
###begin p 89
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
(B) bIGF1RKO-/- mice were viable, but grew slowly (here at 6 wk of age).
###end p 89
###begin p 90
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
(C) Frontal brain sections from adult bIGF1RKO-/- mutants revealed marked microcephaly.
###end p 90
###begin p 91
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
(D) After severe growth retardation, bIGF1RKO-/- mice caught up with normal size at around 4 mo (left panel) and body weight at 12 mo was not different from control littermates (right panel; data represent males).
###end p 91
###begin p 92
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 83 84 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 114 115 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
(E) bIGF1RKO-/- mice showed the same average lifespan as controls (835 d +/- 34 d, n = 19 control 836 d +/- 28 d, n = 42). Male and female data were very similar and thus combined.
###end p 92
###begin p 93
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
(F) Adult bIGF1RKO-/- mice had elevated fasting glycemia and were markedly glucose intolerant.
###end p 93
###begin p 94
###xml 173 176 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
(G) Serum IGF-I was significantly decreased at 4 wk, but increased at 8 wk. IGF-I levels continued to be 30%-40% increased throughout adult life (unpublished data). bIGF1RKO-/- did not perform in standard behavioral testing.
###end p 94
###begin p 95
(308 KB PDF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin title 97
Activity, Nutrition, and Behavioral Analysis
###end title 97
###begin p 98
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
(A) Circadian profiles of physical activity were identical in bIGF1RKO+/- and control mice. Males and females behaved similarly and are shown together.
###end p 98
###begin p 99
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
(B) Daily food (left) and water consumption (right) did not differ between bIGF1RKO+/- mice and controls.
###end p 99
###begin p 100
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
(C) Short term spatial memory was unaffected in bIGF1RKO+/- males (right) and females (left): in all groups, mice preferred to explore the new area in a Y-maze.
###end p 100
###begin p 101
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
(D) bIGF1RKO+/- mice behaved similarly as controls in the open field test (unpublished data). However, exploratory behavior was selectively impaired in bIGF1RKO+/- males as shown by the novel object test.
###end p 101
###begin p 102
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b002">2</xref>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
(E) When testing anxiety in an O-maze, bIGF1RKO+/- females and controls behaved similarly, whereas bIGF1RKO+/- males were less anxious (p < 0.05, Mann-Whitney test). Note that males of B6/129-F1 hybrid genetic background generally display higher levels of anxiety than females [2]. Collectively, we did not find significant behavioral differences, other than slightly impaired exploration and reduced anxiety in bIGF1RKO+/- males.
###end p 102
###begin p 103
(92 KB PDF)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin title 105
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
Activation of IGF-1R in Adult bIGF1RKO+/- Brain
###end title 105
###begin p 106
(A) IGF-1R was significantly underphoshorylated in mutant muscle (hind-limb) and hypothalamus, and overphosphorylated in cerebral cortex.
###end p 106
###begin p 107
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(B) When ME was separated from the rest of the hypothalamus, underphophorylation located to ME only. * p < 0.05, ** p < 0.01, *** p < 0.001; (au), arbitrary units.
###end p 107
###begin p 108
(52 KB PDF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin title 110
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 70 74 <span type="species:ncbi:10090">Mice</span>
Variation of Lifespan and Mortality in bIGF1RKO+/- (Blue) and Control Mice (Red)
###end title 110
###begin p 111
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
(A) Proportion of mice that died within a given age range. The distribution was significantly narrower in bIGF1RKO+/- mice compared to controls (p < 0.01; F-test). 80% of the mutant mice died within a 33-wk interval, whereas the same proportion of control deaths occurred over a 69-wk period.
###end p 111
###begin p 112
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
(B) Mortality in control mice showed a normal increase with age. Mortality in bIGF1RKO+/- mutants occurred much later but increased rapidly after 120 wk. Mortality above 150 wk was 1.0 for both groups.
###end p 112
###begin p 113
(52 KB PDF)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin title 116
###xml 50 54 <span type="species:ncbi:10090">Mice</span>
Early Postnatal Nutrient Restriction in Wild Type Mice Inhibited the Development of Somatotropic Function
###end title 116
###begin p 117
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
(A) Nutrient restriction was achieved by increasing the litter size at birth to ten sucklings per mother, resulting in less mother's milk, and comparing with litters trimmed to six sucklings, which ensured normal nutrient supply. After 2 wk, all mice were fed with rodent chow ad libitum. Growth of restricted mice was progressively delayed (p < 0.001, from day 2 onwards).
###end p 117
###begin p 118
###xml 251 255 <span type="species:ncbi:10090">mice</span>
(B) Left: early nutrient restriction reversibly diminished leptinemia. Glycemia and other nutritional markers behaved similarly (unpublished data). Right: hypothalamic GHRH expression (relative to beta-actin) was significantly decreased in restricted mice at 10 d.
###end p 118
###begin p 119
###xml 61 65 <span type="species:ncbi:10090">mice</span>
(C) Pituitary GH content was conspicuously low in restricted mice at 20 d, while plasma IGF-I was decreased under nutrient restriction and also thereafter, under ad libitum feeding.
###end p 119
###begin p 120
(76 KB PDF)
###end p 120
###begin p 121
Click here for additional data file.
###end p 121
###begin title 122
Functional Development of the Somatotropic Axis Depends on IGF-1R Signaling
###end title 122
###begin p 123
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b003">3</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b034">34</xref>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b004">4</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060254-b005">5</xref>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
Collectively, our results suggest that the functional development of the somatotropic axis depends on IGF-1R signaling (left drawing). Reduced IGF-I signaling in the brain during early life, as with bIGF1RKO+/- mice, retards somatotropic development and leads to adult GH deficiency. Reversely, it is possible that IGF-I, produced as a normal response to nutrition, stimulates brain IGF-1R and induces GHRH and Pit-1 production, eventually translating as a positive feedback into increased GH and IGF-I [3]. This would be different from adult physiology (right drawing), characterized by negative feedback of peripheral IGF-I to hypothalamic IGF-1R, thereby inhibiting GHRH and GH secretion [34,4,5]. It seems possible that this neuroendocrine plasticity of somatotropic function during early postnatal development determines individual endocrine life trajectories.
###end p 123
###begin p 124
(45 KB PDF)
###end p 124
###begin p 125
Click here for additional data file.
###end p 125
###begin title 126
Adult Body Composition at 10 mo of Age
###end title 126
###begin p 127
(56 KB DOC)
###end p 127
###begin p 128
Click here for additional data file.
###end p 128
###begin title 129
AT in Percent of Body Weight
###end title 129
###begin p 130
(52 KB DOC)
###end p 130
###begin p 131
Click here for additional data file.
###end p 131
###begin title 132
Blood Biochemistry at 4 mo of Age
###end title 132
###begin p 133
(47 KB DOC)
###end p 133
###begin p 134
Click here for additional data file.
###end p 134
###begin title 135
Supplementary Results
###end title 135
###begin p 136
(74 KB DOC)
###end p 136
###begin p 137
Click here for additional data file.
###end p 137
###begin p 138
We thank B. Ducos for ligand binding assays; O. Bischof for critical reading; Alex Edelman and Associates (SARL) for language revision; I. Renault for veterinary care; A.F. Parlow, G. Thordarson, G. Gudmundur, F. Talamantes, and C. Rougeot for antibodies and reagents.
###end p 138
###begin title 139
Abbreviations
###end title 139
###begin p 140
acid labile subunit
###end p 140
###begin p 141
adipose tissue
###end p 141
###begin p 142
brain-specific IGF-1 receptor knockout
###end p 142
###begin p 143
central nervous system
###end p 143
###begin p 144
growth hormone
###end p 144
###begin p 145
growth hormone releasing hormone
###end p 145
###begin p 146
insulin-like growth factor
###end p 146
###begin p 147
insulin-like growth factor receptor
###end p 147
###begin p 148
immunohistochemistry
###end p 148
###begin p 149
insulin-receptor substrate
###end p 149
###begin p 150
median eminence
###end p 150
###begin p 151
not significant
###end p 151
###begin p 152
somatostatin
###end p 152
###begin title 153
References
###end title 153
###begin article-title 154
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (Igf1r)
###end article-title 154
###begin article-title 155
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
###end article-title 155
###begin article-title 156
beta-cell specific deletion of the IGF-1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass
###end article-title 156
###begin article-title 157
Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes
###end article-title 157
###begin article-title 158
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
###end article-title 158
###begin article-title 159
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Assessment of growth parameters and life span of GHR/BP gene-disrupted mice
###end article-title 159
###begin article-title 160
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span
###end article-title 160
###begin article-title 161
###xml 24 28 <span type="species:ncbi:10090">mice</span>
GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function
###end article-title 161
###begin article-title 162
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production
###end article-title 162
###begin article-title 163
###xml 73 77 <span type="species:ncbi:10090">mice</span>
IGF-1 receptor regulates life span and resistance to oxidative stress in mice
###end article-title 163
###begin article-title 164
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice
###end article-title 164
###begin article-title 165
Brain IRS2 signaling coordinates life span and nutrient homeostasis
###end article-title 165
###begin article-title 166
###xml 2 12 <span type="species:ncbi:6239">C. elegans</span>
A C. elegans mutant that lives twice as long as wild-type
###end article-title 166
###begin article-title 167
A conserved regulatory system for aging
###end article-title 167
###begin article-title 168
A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function
###end article-title 168
###begin article-title 169
Role of insulin-like signalling in Drosophila lifespan. Trends Biochem
###end article-title 169
###begin article-title 170
Functionally significant insulin-like growth factor I receptor mutations in centenarians
###end article-title 170
###begin article-title 171
###xml 137 142 <span type="species:ncbi:9606">human</span>
Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control
###end article-title 171
###begin article-title 172
###xml 37 42 <span type="species:ncbi:9606">human</span>
Reduced insulin/IGF-1 signalling and human longevity
###end article-title 172
###begin article-title 173
Is growth hormone deficiency a beneficial adaptation to aging? Evidence from experimental animals
###end article-title 173
###begin article-title 174
The plasticity of aging: insights from long-lived mutants
###end article-title 174
###begin article-title 175
Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity
###end article-title 175
###begin article-title 176
Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis
###end article-title 176
###begin article-title 177
###xml 20 30 <span type="species:ncbi:6239">C. elegans</span>
Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and lifespan
###end article-title 177
###begin article-title 178
###xml 14 24 <span type="species:ncbi:6239">C. elegans</span>
Regulation of C. elegans life-span by insulinlike signaling in the nervous system
###end article-title 178
###begin article-title 179
###xml 48 70 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Regulation of lifespan by sensory perception in Caenorhabditis elegans
###end article-title 179
###begin article-title 180
###xml 14 24 <span type="species:ncbi:6239">C. elegans</span>
Regulation of C. elegans longevity by specific gustatory and olfactory neurons
###end article-title 180
###begin article-title 181
Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body
###end article-title 181
###begin article-title 182
Long-lived Drosophila with overexpressed dFOXO in adult fat body
###end article-title 182
###begin article-title 183
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Comparing adiposity profiles in three mouse models with altered GH signaling
###end article-title 183
###begin article-title 184
Effect of growth hormone on susceptibility to diet-induced obesity
###end article-title 184
###begin article-title 185
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity
###end article-title 185
###begin article-title 186
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice
###end article-title 186
###begin article-title 187
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice
###end article-title 187
###begin article-title 188
###xml 6 10 <span type="species:ncbi:10090">mice</span>
Dwarf mice and the ageing process
###end article-title 188
###begin article-title 189
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene
###end article-title 189
###begin article-title 190
Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control
###end article-title 190
###begin article-title 191
Regulation of insulin-like growth factor-I in starvation and injury
###end article-title 191
###begin article-title 192
Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth
###end article-title 192
###begin article-title 193
###xml 73 79 <span type="species:ncbi:9606">humans</span>
What are the effects of maternal and pre-adult environments on ageing in humans, and are there lessons from animal models
###end article-title 193
###begin article-title 194
###xml 29 34 <span type="species:ncbi:9606">human</span>
Developmental plasticity and human disease: research directions
###end article-title 194
###begin article-title 195
###xml 27 32 <span type="species:ncbi:9606">human</span>
Targeted expression of the human uncoupling protein 2 (hUCP2) to adult neurons extends life span in the fly
###end article-title 195
###begin article-title 196
###xml 63 86 <span type="species:ncbi:7227">drosophila melanogaster</span>
Neuronal expression of p53 dominant-negative proteins in adult drosophila melanogaster extends life span
###end article-title 196
###begin article-title 197
###xml 61 65 <span type="species:ncbi:9615">dogs</span>
A single IGF1 allele is a major determinant of small size in dogs
###end article-title 197
###begin article-title 198
###xml 29 33 <span type="species:ncbi:9615">dogs</span>
###xml 38 44 <span type="species:ncbi:9606">humans</span>
Comparative longevity of pet dogs and humans: implications for gerontology research
###end article-title 198
###begin article-title 199
A nationwide survey of mortality in acromegaly
###end article-title 199
###begin article-title 200
Plasma insulin-like growth factor I levels in the elderly: relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality
###end article-title 200
###begin article-title 201
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular
###end article-title 201
###begin article-title 202
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout
###end article-title 202
###begin article-title 203
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
###end article-title 203
###begin article-title 204
###xml 77 82 <span type="species:ncbi:9606">human</span>
The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components
###end article-title 204
###begin article-title 205
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Selective alteration at the growth-hormone- releasing-hormone nerve terminals during aging in GHRH-green fluorescent protein mice
###end article-title 205
###begin p 206
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NesCre</italic>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
Author contributions. LK, CDMF, YLB, and MH designed the experiments. LK, CDMF, JD, PL, PC, LP, CL, AB, JE, and MH performed the experiments and analyzed the data. RK provided NesCre mice and advice. MH wrote the manuscript. LK, CDMF, JD, PL, PC, LP, CL, AB, RK, JE, YLB, and MH discussed the results and commented on the manuscript.
###end p 206
###begin p 207
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. Funding Agence National pour la Recherche (grant NT05-3 42491) and European Union Network of Excellence LifeSpan (036894), Le Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT), and Groupement d'Interet Scientifique Institut du Vieillissement sponsored this study with grants to MH and YLB. ARC, Inserm, and MENRT supported LK and CDMF.
###end p 207
###begin p 208
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 208

